How can synthetic control arms & real-world data redefine clinical trial design?
David Clifton, University of Oxford; Mark Winderlich, MorphoSys Inc; Martin Gouldstone, Sensyne Health
About this talk
Synthetic Control Arms (SCAs) have the potential to reduce the number of trial participants, eliminate delays, and lower costs. In this webinar experts from the worlds of clinical trials and clinical AI will present and discuss the factors to consider when planning to use an SCA as part of a clinical trial.
pharmaphorum provides a digital podium for communicating thought leadership and innovation within pharma. Our webinars bring together different stakeholders from across the healthcare spectrum to drive fresh thinking and novel solutions that deliver better outcomes for patients.…